Advanced search
Publication Cover
Pharmacogenomics Volume 11, 2010 - Issue 1
Submit an article Journal homepage
219
Views
0
CrossRef citations to date
0
Altmetric
Research Article

TaqMan® Low-Density Arrays and Analysis by Artificial Neuronal Networks Predict Response to Neoadjuvant Chemoradiation in Esophageal Cancer

Ute Warnecke-Eberz1 Center for Integrated Oncology (CIO), University Hospital of Cologne, Kerpener Straße 62, 50937Köln, Germany. Tel.: +49 221 478 6011 Fax: +49 221 478 [email protected]View further author information
,
Ralf Metzger1 Center for Integrated Oncology (CIO), University Hospital of Cologne, Kerpener Straße 62, 50937Köln, Germany. Tel.: +49 221 478 6011 Fax: +49 221 478 [email protected]View further author information
,
Elfriede Bollschweiler1 Center for Integrated Oncology (CIO), University Hospital of Cologne, Kerpener Straße 62, 50937Köln, Germany. Tel.: +49 221 478 6011 Fax: +49 221 478 [email protected]View further author information
,
Stephan E Baldus2 University of Duesseldorf, Duesseldorf, GermanyView further author information
,
Rolf P Mueller1 Center for Integrated Oncology (CIO), University Hospital of Cologne, Kerpener Straße 62, 50937Köln, Germany. Tel.: +49 221 478 6011 Fax: +49 221 478 [email protected]View further author information
,
Hans P Dienes1 Center for Integrated Oncology (CIO), University Hospital of Cologne, Kerpener Straße 62, 50937Köln, Germany. Tel.: +49 221 478 6011 Fax: +49 221 478 [email protected]View further author information
,
Arnulf H Hoelscher1 Center for Integrated Oncology (CIO), University Hospital of Cologne, Kerpener Straße 62, 50937Köln, Germany. Tel.: +49 221 478 6011 Fax: +49 221 478 [email protected]View further author information
&
Paul M Schneider3 University Hospital Zurich, Zurich, SwitzerlandView further author information
 show all
Pages 55-64 | Published online: 18 Dec 2009

Bibliography

  • Rouvelas I , ZengW, LindbldM, ViklundP, YeW, LagergrenJ. Survival after surgery for oesophageal cancer: a population-based study. Lancet. Oncol.6 , 864–870 (2005).
  • Sherman CA , TurrisiAT, WallaceMB, ReedCE: Locally advanced esophageal cancer.Curr. Treat. Options Oncol.3 , 475–485 (2002).
  • Walsh TN , NoonanN, HollywoodD, KellyA, KeelingN, HennessyTP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.N. Engl. J. Med.335 , 462–467 (1996).
  • Kaklamanos I , WalkerG, FerryK, FranceschiD, LivingstoneA: Neoadjuvant treatment for respectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials.Ann. Surg. Oncol.10 , 754–761 (2003).
  • Urschel J , VasanH: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for respectable esophageal cancer.Am. J. Surg.185 , 538–543 (2003).
  • Fiorica F , Di Bona D, Schepis F et al.: Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut53 , 925–930 (2004).
  • Gebski V , BurmeisterB, SmithersBM, FooK, ZalcbergJ, SimesJ: Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.Lancet Oncol.8 , 226–234 (2007).
  • Schneider PM , BaldusSE, MetzgerR et al.: Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.Ann. Surg.242 , 684–692 (2005).
  • Haffty BG , GlazerPM: Molecular markers in clinical radiation oncology.Oncogene22 , 5915–5925 (2003).
  • Lagarde SM , ten Kate FJW, Richel DJ, Offerhaus GJA, Lanschot JJB: Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction. Ann. Surg. Oncol.14 , 977–991 (2006).
  • Warnecke-Eberz U , MetzgerR, MiyazonoF et al.: High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.Clin. Cancer Res.10 , 3794–3799 (2004).
  • Miyazono F , MetzgerR, Warnecke-EberzU et al.: Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histophathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br. J. Cancer16 , 666–672 (2004).
  • Baldus SE , MönigSP, SchröderW et al.: Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation.Pathologe25 , 4780–4788 (2004).
  • Junker K , Thomas, Schulmann K, Klinke V, Boss U, Müller KM: Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J. Cancer Res. Clin. Oncol.123 , 469–477 (1997).
  • Kato J , KuwabaraY, MitaniM et al.: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy.Int. J. Cancer95 , 92–95 (2001).
  • Miyata H , DokiY, ShiozakiH et al.: CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.Clin. Cancer Res.6 , 4859–4865 (2000).
  • Heeren PA , KloppenbergFW, HollemaH, MulderNH, NapRE, PlukkerJT: Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.Anticancer Res.24 , 2579–2583 (2004).
  • Sohda M , IshikawaH, MasudaN et al.: Pretreatment evaluation of combined HIF-1a, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer.Int. J. Cancer110 , 838–844 (2004).
  • Schneider S , UchidaK, BrabenderJ et al.: Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.J. Am. Coll. Surg.200 , 336–344 (2005).
  • Ikeguchi M , SakataniT, UetaT et al.: The expression of thymidine phosphorylase suppresses spontaneous apoptosis of cancer cells in esophageal squamous cell carcinoma.Pathobiology69 , 36–43 (2001).
  • Akamatsu M , MatsumotoT, OkaK et al.: c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma.Int . J. Radiat. Oncol. Biol. Phys.57 , 1323–1327 (2003).
  • Joshi MB , ShirotaY, DanenbergKD et al.: High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.Clin. Cancer Res.11 , 2215–2221 (2005).
  • Abdel-Latif MM , O‘RiordanJ, WindleHJ et al.: NF-κB activation in esophageal adenocarcinoma: relationship to Barrett‘s metaplasia, survival, and response to neoadjuvant chemoradiotherapy.Ann. Surg.239 , 491–500 (2004).
  • Yamashita K , TanakaY, MimoriK, InoueH, MoriM: Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.Int. J. Cancer110 , 201–207 (2004).
  • Kulke MH , OdzeRD, MuellerJD, WangH, RedstonM, BertagnolliMM: Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.J. Thorac. Cardiovasc. Surg.127 , 1579–1586 (2004).
  • Kandioler-Eckersberger D , LudwigC, RudasM et al.: TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.Clin. Cancer Res.6 , 50–56 (2000).
  • Nakamura T , HayashiK, OtaM, DieH, TakasakiK, MitsuhashiM: Expression of p21(Waf1/Cip1) predicts response and survival of esophageal cancer patients treated by chemoradiotherapy.Dis. Esophagus17 , 315–321 (2004).
  • Beardsmore DM , VerbekeCS, DaviesCL, GuillouPJ, ClarkGW: Apoptotic and proliferative indexes in esophageal cancer: predictors of response to neoadjuvant therapy [corrected].J. Gastrointest. Surg.7 , 77–86 (2003).
  • Kishi K , DokiY, MiyataH, YanoM, YasudaT, MondenM: Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer.Br. J. Surg.89 , 597–603 (2002).
  • Livak KJ , SchmittgenTD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC[T])method.Methods25 , 402–408 (2001).
  • Griner PF , MayewskiRJ, MushlinAI, GreenlandP: Selection and interpretation of diagnostic tests and procedures.Ann. Intern. Med.94 , 555–600 (1981).
  • Hilgers RA : Distribution-free confidence bounds for ROC curves.Meth. Inform. Med.30 , 96–101 (1991).
  • Hensler K , WaschulzikT, MonigS, MaruyamaK, HölscherAH, BollschweilerE: Quality-assured efficient engineering of feedforward neural networks [QUEEN] – pretherapeutic estimation of lymph node status in patients with gastric carcinoma.Methods Inf. Med.44 , 647–654 (2005).
  • Stahl M , StuschkeM, LehmannN et al.: Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J. Clin. Oncol.23 , 2310–2317 (2005).
  • Prenzel K , KonigA, SchneiderP et al.: Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.Ann. Surg. Oncol.14 , 954–959 (2007).
  • Westerterp M , van Westreenen HL, Reitsma JB et al.: Esophageal cancer: CT, Endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy – systematic review. Radiology236 , 841–851 (2005).
  • Leichman L , LawrenceD, LeichmanCG et al.: Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5 fluorouracil and radiation: characterization and exploratory analysis with survival.J. Chemother.18 , 514–524 (2006).
  • Hisamitsu K , TsujitaniS, YamaguchiK, FukudaK, KonishiI, KaibaraN: Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stroma cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.Anticancer Res.24 , 2495–2501 (2004).
  • Bollschweiler E , MonigS, HenslerK, BaldusSE, MaruyamaK, HölscherAH: Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study.Ann. Surg. Oncol.11 , 506–511 (2004).
  • Xu Y , SelaruFM, YinJ et al.: Artificial neuronal networks and gene filtering distinguish between global gene expression profiles of Barrett‘s esophagus and esohageal cancer.Cancer Res.62 , 3493–3497 (2002).
  • Kan T , ShimadaY, SatoF et al.: Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma.Ann. Surg. Oncol.11 , 1070–1078 (2004).
  • Kihara C , TsunodaT, TanakaT et al.: Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene expression profiles.Cancer Res.61 , 6474–6479 (2001).
  • Luthra R , Wu T-T, Luthra MG et al.: Gene expression profiling of localized esophageal carcinomas: association of pathologic response to preoperative chemoradiation. J. Clin. Oncol.24 , 295–297 (2006).
  • Ng T , DipetrilloT, PurvianceJ, SafranH: Multimodality treatment of esophageal cancer: a review of the current status and future directions.Curr. Oncol. Rep.8 , 174–182 (2006).
  • Safran H , DipetrilloT, AkermanP et al.: Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma.Int. J. Radiat. Oncol. Biol. Phys.67 , 405–409 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.